Washington: Scientists have adapted what is typically a cancer therapeutic technique, CAR-T cell therapy, for the purpose of eliminating the SARS-CoV-2 virus, according to a study.
The team of scientists at the nonprofit biomedical research institution, The Jackson Laboratory for Genomic Medicine, led by Derya Unutmaz, demonstrated several immuno-based strategies to explore the treatment and prevention of COVID-19.
The first immunotherapy method in the study, published in Clinical and Translational Immunology, focused on the spike protein present in SARS-CoV-2 and the receptor on the host cell, angiotensin-converting enzyme 2 (ACE2).
